Lisanti Capital Growth LLC Purchases New Stake in Phreesia, Inc. (NYSE:PHR)

Lisanti Capital Growth LLC bought a new stake in shares of Phreesia, Inc. (NYSE:PHR - Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 41,545 shares of the company's stock, valued at approximately $1,062,000. Lisanti Capital Growth LLC owned approximately 0.07% of Phreesia at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in the company. Diversified Trust Co grew its stake in Phreesia by 83.2% during the 1st quarter. Diversified Trust Co now owns 44,616 shares of the company's stock valued at $1,140,000 after purchasing an additional 20,260 shares during the last quarter. Bessemer Group Inc. grew its stake in Phreesia by 23.2% during the 1st quarter. Bessemer Group Inc. now owns 47,758 shares of the company's stock valued at $1,222,000 after purchasing an additional 8,978 shares during the last quarter. Oppenheimer Asset Management Inc. purchased a new stake in Phreesia during the 1st quarter valued at about $205,000. QRG Capital Management Inc. grew its stake in Phreesia by 8.0% during the 1st quarter. QRG Capital Management Inc. now owns 11,118 shares of the company's stock valued at $284,000 after purchasing an additional 827 shares during the last quarter. Finally, SG Americas Securities LLC purchased a new stake in Phreesia during the 1st quarter valued at about $462,000. Hedge funds and other institutional investors own 92.10% of the company's stock.

Insider Buying and Selling at Phreesia

In other Phreesia news, SVP David Linetsky sold 4,499 shares of the stock in a transaction that occurred on Wednesday, April 16th. The stock was sold at an average price of $23.73, for a total transaction of $106,761.27. Following the completion of the transaction, the senior vice president now owns 217,239 shares of the company's stock, valued at $5,155,081.47. This represents a 2.03% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Lisa Egbuonu-Davis sold 2,802 shares of the stock in a transaction that occurred on Thursday, June 26th. The shares were sold at an average price of $27.67, for a total value of $77,531.34. Following the transaction, the director now directly owns 22,037 shares of the company's stock, valued at $609,763.79. The trade was a 11.28% decrease in their position. The disclosure for this sale can be found here. Insiders sold 50,605 shares of company stock valued at $1,256,069 over the last quarter. 5.50% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on PHR shares. Wall Street Zen upgraded Phreesia from a "hold" rating to a "buy" rating in a research note on Sunday, June 1st. Canaccord Genuity Group lowered their target price on Phreesia from $35.00 to $34.00 and set a "buy" rating on the stock in a research note on Thursday, May 29th. DA Davidson lowered their target price on Phreesia from $36.00 to $34.00 and set a "buy" rating on the stock in a research note on Monday, April 14th. Truist Financial upped their target price on Phreesia from $34.00 to $35.00 and gave the stock a "buy" rating in a research note on Thursday, May 29th. Finally, KeyCorp lowered their target price on Phreesia from $30.00 to $28.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 16th. Twelve equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, Phreesia presently has a consensus rating of "Buy" and a consensus price target of $31.64.

Phreesia Price Performance

NYSE PHR traded up $0.50 during trading hours on Friday, reaching $28.45. The company's stock had a trading volume of 2,170,779 shares, compared to its average volume of 450,959. The firm has a market capitalization of $1.69 billion, a price-to-earnings ratio of -38.45 and a beta of 0.68. Phreesia, Inc. has a 1-year low of $17.07 and a 1-year high of $30.53. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.95 and a quick ratio of 1.95. The company's 50-day moving average is $25.54 and its two-hundred day moving average is $26.11.

Phreesia (NYSE:PHR - Get Free Report) last released its quarterly earnings results on Wednesday, May 28th. The company reported ($0.07) earnings per share for the quarter, topping analysts' consensus estimates of ($0.13) by $0.06. The company had revenue of $115.94 million during the quarter, compared to analysts' expectations of $115.00 million. Phreesia had a negative return on equity of 16.23% and a negative net margin of 9.83%. Phreesia's quarterly revenue was up 14.5% compared to the same quarter last year. During the same quarter in the prior year, the firm posted ($0.05) EPS. On average, equities analysts predict that Phreesia, Inc. will post -1.1 EPS for the current year.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.